Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Mar'17
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
Compare Balance Sheet Results of Venmax Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.24
2.99
2.25
75.25%
Share Warrants & Outstandings
Total Reserve
-5.90
7.80
-13.70
-175.64%
Shareholder's Funds
4.41
10.79
-6.38
-59.13%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.09
-0.09
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.09
-0.09
-100.00%
Deferred Tax Assets / Liabilities
0.00
0.01
-0.01
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
0.10
-0.10
-100.00%
Current Liabilities
Trade Payables
0.63
0.95
-0.32
-33.68%
Other Current Liabilities
0.08
0.46
-0.38
-82.61%
Short Term Borrowings
0.05
3.81
-3.76
-98.69%
Short Term Provisions
0.00
0.18
-0.18
-100.00%
Total Current Liabilities
0.76
5.40
-4.64
-85.93%
Total Liabilities
5.17
16.30
-11.13
-68.28%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.04
4.84
-4.80
-99.17%
Less: Accumulated Depreciation
0.00
3.96
-3.96
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
0.88
-0.84
-95.45%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.35
-0.35
-100.00%
Long Term Loans & Advances
0.00
0.08
-0.08
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.04
1.31
-1.27
-96.95%
Current Assets Loans & Advances
Current Investments
0.00
3.52
-3.52
-100.00%
Inventories
0.06
4.46
-4.40
-98.65%
Sundry Debtors
0.95
1.90
-0.95
-50.00%
Cash and Bank
2.48
4.83
-2.35
-48.65%
Other Current Assets
0.03
0.03
0.00
0.00%
Short Term Loans and Advances
1.61
0.24
1.37
570.83%
Total Current Assets
5.13
14.98
-9.85
-65.75%
Net Current Assets (Including Current Investments)
4.37
9.58
-5.21
-54.38%
Total Current Assets Excluding Current Investments
5.13
11.47
-6.34
-55.27%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5.17
16.30
-11.13
-68.28%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.05
3.90
-3.85
-98.72%
Book Value per share (adjusted)
-1.26
36.08
-37.34
-103.49%
Annual - Borrowings
Borrowings 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Annual - Investments
No Investments in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 5.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024






